News
News | Pharmaceutical Experts Enter Pharma Companies, Driving New Growth for the Industry
Date:
02 Aug,2023
To better drive corporate technological innovation and foster scientific-technological exchange, the "Pharmacology Experts Visit Pharmaceutical Companies to Unlock New Growth Opportunities" event—organized by the Wenling Pharmaceutical Association as part of Wanbangde Science and Technology Association Activity Month—successfully took place on July 12 at the Wanbangde Pharmaceutical Group, coinciding with National Science and Technology Workers' Day.
Chen Caiming, President of the Wenling Pharmaceutical Association, led more than 20 pharmaceutical experts from medical institutions including Wenling First People's Hospital, Taizhou Cancer Hospital, Taizhou Hospital of Traditional Chinese and Western Medicine, Taizhou Orthopedics & Traumatology Hospital, Wenling Municipal Hospital of Traditional Chinese Medicine, and Wenling Municipal Maternal and Child Health Care Hospital. Accompanied by Zhang Fangrong, Chief of the Science and Technology Division at the Wenling Market Supervision Administration, the delegation visited Wanbangde Pharmaceutical Group for exchanges and guidance. They were joined by Li Li, General Manager of Wanbangde Pharmaceutical Group, along with Deputy General Managers Lin Hong, Ma Jian, and Hu Gensheng.
1. Hands-on observation to gain a direct and in-depth understanding of the company’s "pulse"
That day, the team of pharmaceutical experts toured the company’s pharmaceutical exhibition hall and its Instrument Center Laboratory, gaining a firsthand understanding of the company’s production operations, core flagship products, R&D innovations, and talent development initiatives. Throughout the visit, the experts enthusiastically praised Wanbangde’s robust and diverse product portfolio, its groundbreaking research achievements, and its state-of-the-art, fully equipped experimental facilities.
2. Facilitating connections and bridging gaps to help businesses upgrade and advance.
Chen Caiming, President of the Wenling City Pharmaceutical Association, delivers a speech Opening remarks
The subsequent "Experts Offer Insights to Support Pharmaceutical Companies" At the seminar, Chairman Chen Caiming delivered the opening remarks first. He stated that the event was organized in response to the city's Science and Technology Association's requirements and to mark the 2023 National Day of Science and Technology Workers. "Lighting the Spiritual Torch" The event, themed around [insert theme here], is organized by the Wenling Pharmaceutical Association and hosted by the Pharmaceutical Engineering Professional Committee and the Science & Technology Association of Wanbangde Pharmaceutical Group. "Pharmacology Experts Enter Pharmaceutical Companies to Drive New Growth" Topic: Jointly exploring how to help businesses expand into the end-market under the backdrop of national centralized procurement.
Li Li, General Manager of Wanbangde Pharmaceutical Group, delivers a speech.
Mr. Li first expressed the company's gratitude on behalf of the organization for the visit of today's esteemed experts.
He mentioned that Wanbangde Pharmaceutical Group has now preliminarily completed its macro strategic layout, focusing on three key areas: first, building a modern Chinese medicine system centered around Ginkgo Biloba Dropping Pills; second, expanding the market sales of Huperzine A Injection—a globally innovative product and the company’s exclusive domestic water-soluble injectable formulation; and third, leveraging the company’s advanced API production base to capitalize on the integrated "API + Formulation" advantage, thereby reducing costs and strengthening its pipeline of generic drugs targeting respiratory, digestive, and other therapeutic areas.
Wanbangde Pharmaceutical Group has entered a strategically critical phase of development. How to transform and tackle market challenges, as well as how to effectively bring our products to the market—providing healthcare professionals with more options and delivering superior services to patients—is now the company’s top priority for future growth. We look forward to hearing valuable insights and recommendations from the esteemed pharmaceutical experts in attendance.
Kong Weijing, Marketing Director of the pharmaceutical group, delivers a product presentation.
Marketing Director Kong Weijing delivered a company product presentation at the conference, highlighting the key advantages and unique features of core products such as Ginkgo Leaf Droplets, Huperzine A Injection, and Phloroglucinol Injection.
3. Experts Offer Advice and Insights—"Diagnosing the Situation"
Experts in the audience spoke one by one, discussing ways to strengthen corporate communication and enhance coverage among local medical institutions in Wenling.
“Companies are encouraged to prioritize promoting Wengling’s local identity, leveraging new media platforms, industry association annual meetings, and academic lectures to expand the reach and impact of their outreach efforts.” “Medical companies and research institutions can achieve mutual growth by collaborating—companies are advised to share resources and projects for clinical trial research, which will not only support cutting-edge scientific advancements but also accelerate the commercialization of laboratory innovations.” “Market demand for our products remains strong. With Wande’s diverse product portfolio already well-established and widely applicable across various fields, we’re committed to delivering comprehensive maintenance services, ensuring our presence continues to thrive and flourish in the Wengling market.”
Each piece of advice is thoughtful, sincere, and tailored to prescribe a path for businesses to achieve new growth—helping them navigate challenges, overcome obstacles, and elevate their operations to the next level.
4. Break down barriers between medical institutions and enterprises, adapt scientifically, and jointly pursue growth and development.
Chen Caiming, President of the Wenling City Pharmaceutical Association Deliver a speech
After listening to the expert presentations, Chairman Chen Caiming delivered a speech. He expressed his hope that this event would serve as a "catalyst" to foster deeper collaboration in the following four areas:
First, we must deeply cultivate the fertile ground for scientific research—our pharmaceutical association boasts a wealth of talented individuals. We hope that enterprises can provide valuable resources and platforms to support our research projects, helping us accelerate technological breakthroughs and the commercialization of innovative findings.
Second, let's jointly build a healthy town, with companies actively cooperating in areas such as production and sales to collaboratively establish a traditional Chinese medicine base.
Third, we must break down barriers between medical institutions and pharmaceutical companies, bridging the divide between clinical practice and research. We encourage companies to channel more of their projects into local hospitals in Wenling, strengthening collaborative GCP-based drug clinical trials and working together to advance academic development.
Fourth, we must respond scientifically and flexibly adjust our sales strategies, hoping that companies will pay more attention to the Wenling market, enabling them to better implement product distribution at lower levels and ultimately bring high-quality products that benefit the people of Wenling.
Zhang Fangrong, Chief of the Department at Wenling City Market Supervision Administration Deliver a concluding speech
Director Zhang Fangrong noted that, as the only large-scale pharmaceutical company in Wenling, Wanbangde Pharmaceutical Group is experiencing robust growth—so much so that its momentum could aptly be described as "taking off." Today, the group’s pharmaceutical industry has already reached substantial scale, with products that clearly stand out from the crowd. Moreover, Wanbangde boasts strong R&D capabilities and innovation prowess, making us confident that its future market prospects will undoubtedly be bright.
At the conclusion of the meeting, Director Zhang once again expressed gratitude to Wanbangde Pharmaceutical Group and the experts present for their strong support of this event. Drug safety is directly tied to public health, and he emphasized the importance of strengthening collaboration between medical institutions and pharmaceutical companies to jointly create a new hub for pharmaceutical industry development—driving high-quality progress that fully supports China’s Healthy China initiative.
Related Recommendations